Thrombin Receptor Agonist 凝血酶受体兴奋剂
adrenergic receptor agonist 肾上腺素能受体增效剂
-ht receptor agonist ht4受体激动剂
2 receptor agonist 受体激动剂
5-hydroxytryptamine receptor agonist 羟色胺受体激动剂
Adenosine A2 receptor agonist 腺苷A2受体激动剂
Beta2 adrenergic receptor agonist 受体激动剂
-receptor agonist 受体激动剂
BYETTA is the first FDA-approved GLP-1 receptor agonist for the treatment of type 2 diabetes.
百泌达是FDA批准的治疗2型糖尿病的首个GLP - 1受体激动剂药物。
BYDUREON and BYETTA belong to the glucagon-like peptide-1 (GLP-1) receptor agonist class of medications.
BYDUREON和百泌达(BYETTA)都属于胰高血糖素样肽(GLP - 1)受体激动剂类药物。
Provided herein is a method of reversing or preventing a target cell's resistance to a death receptor agonist.
本文提供了反转或阻止靶细胞对死亡受体激动剂的抗性的方法。
应用推荐